Ovarian cancer and hormone replacement therapy in the Million Women Study
Top Cited Papers
- 19 April 2007
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 369 (9574) , 1703-1710
- https://doi.org/10.1016/s0140-6736(07)60534-0
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Menopausal Hormone Therapy and Ovarian Cancer Risk in the National Institutes of Health–AARP Diet and Health Study CohortJNCI Journal of the National Cancer Institute, 2006
- Hormonal factors and the risk of invasive ovarian cancer: a population-based case-control studyFertility and Sterility, 2004
- Hormone replacement therapy and incidence of hormone‐dependent cancers in the Norwegian Women and Cancer studyInternational Journal of Cancer, 2004
- Estrogen Replacement Therapy and Ovarian CancerEpidemiology, 2004
- Breast cancer and hormone-replacement therapy in the Million Women StudyThe Lancet, 2003
- Agreement between general practice prescription data and self-reported use of hormone replacement therapy and treatment for various illnessesJournal of Epidemiology and Biostatistics, 2001
- Hormone replacement therapy as a risk factor for epithelial ovarian cancer: Results of a case-control studyPublished by Wolters Kluwer Health ,1998
- Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancerThe Lancet, 1997
- Estrogen Replacement Therapy and Risk of Epithelial Ovarian CancerGynecologic Oncology, 1996
- Differences in Risk Factors for Epithelial Ovarian Cancer by Histologic Type: Results of a Case-Control StudyAmerican Journal of Epidemiology, 1996